Nephria - Model NephroMark™ - Biomarker Tool for AKI

Many of the current biomarkers indicating AKI only appear 48 hours after the initial kidney injury. Nephria Bio’s NephroMark biomarker tool helps healthcare providers scan for a wide array of biomarkers, with the goal of providing earlier diagnoses and earlier interventions when AKI occurs. NephroMark also has an at-home model, allowing AKI patients to monitor their kidney recovery using their smartphones.

The Nephria Bio NephRedi™ and NephRedi+™ dialysis cartridge, the NephroMark™ Biomarker System, and the NephroPatch™ wearable dialysis system are investigative devices only and not available for commercial human use in any jurisdiction. Neither device has received FDA clearance or approval and neither has received CE mark or other competent authority licensure. All images are projected product configuration, final dimensions and features may vary.